Skip to main content
Caplight Logo









EQT Life Sciences

EQT Life Sciences

Amsterdameqtgroup.com

Overview

EQT Life Sciences is a venture capital firm that invests in companies operating in the healthcare, life sciences, oncology, internet of things, and health technology sectors across the United States and Europe.

Year Founded

1988

Portfolio Companies

93

Investments

EQT Life Sciences investments
CompanyDateStageLead
NouscomOct 2026Series DCo-investor
Vaderis TherapeuticsAug 2026Series BCo-investor
XeltisJul 2026Early FundingCo-investor
RQ Biotechnology LimitedJun 2026Series ACo-investor
Neurent MedicalFeb 2026Series CCo-investor
Book a demo to see all 93 portfolio companies

For institutional investors. Book with your work email.

Key People

Fouad Azzam

General Partner

Geraldine O'Keeffe

General Partner, Partner

Alex Lee

Partner

Andreas Dr. Fischer

Partner

Anne Portwich

Partner

Asís Echániz

Partner

Carlos Santana

Partner

Caspar Callerström

Partner

Crosby Cook

Partner

Felice Verduyn - van Weegen

Partner

Georg Stadler

Partner

Hemant Sharma

Partner

Hong Yong Leong

Partner

Isabel De Paoli

Partner, Healthcare

Jan Vesely

Partner

Johannes Reichel

Partner

Book a demo to see all key people

For institutional investors. Book with your work email.

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Portfolio analytics

Caplight clients see full sector, stage and valuation breakdowns for this investor.

Book a demo to see full analytics

For institutional investors. Book with your work email.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Portfolio analytics

Caplight clients see yearly investment pace and funding raised over time.

Book a demo to see full analytics

For institutional investors. Book with your work email.

FAQ

Where is EQT Life Sciences based?

EQT Life Sciences is headquartered in Amsterdam, Netherlands.

When was EQT Life Sciences founded?

EQT Life Sciences was founded in 1988.

How many portfolio companies does EQT Life Sciences have?

EQT Life Sciences has 93 portfolio companies in Caplight's dataset.

What are some companies in EQT Life Sciences's portfolio?

Recent investments visible on Caplight include Nouscom, Vaderis Therapeutics, Xeltis, RQ Biotechnology Limited, Neurent Medical.

What was EQT Life Sciences's most recent investment?

EQT Life Sciences's most recent investment on Caplight was in Nouscom in 2026.

What sectors does EQT Life Sciences focus on?

EQT Life Sciences focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, FinTech, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, FinTech, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Mobility, Transportation & Logistics, Healthcare & Life Sciences, Media, Entertainment & Gaming, FinTech, Healthcare & Life Sciences, Frontier & Industrial Tech, Healthcare & Life Sciences, Enterprise Software, AI, Data & Cloud Infrastructure, Healthcare & Life Sciences, Media, Entertainment & Gaming, Healthcare & Life Sciences, Telecommunications & Networking, Healthcare & Life Sciences, Healthcare & Life Sciences, Consumer & Commerce, Enterprise Software, FinTech, Enterprise Software, FinTech, Healthcare & Life Sciences, Mobility, Transportation & Logistics, Mobility, Transportation & Logistics, Mobility, Transportation & Logistics, Energy & Sustainability, Energy & Sustainability, Energy & Sustainability, Enterprise Software, FinTech, Consumer & Commerce, Real Estate & PropTech, Enterprise Software, Enterprise Software, Media, Entertainment & Gaming, Enterprise Software, Enterprise Software, Mobility, Transportation & Logistics, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, Enterprise Software, Enterprise Software, Enterprise Software, AI, Data & Cloud Infrastructure, Healthcare & Life Sciences, Consumer & Commerce, AI, Data & Cloud Infrastructure, Enterprise Software, Frontier & Industrial Tech, Consumer & Commerce, Frontier & Industrial Tech, Consumer & Commerce, Frontier & Industrial Tech, Consumer & Commerce.

What company stages does EQT Life Sciences focus on?

EQT Life Sciences typically invests at the MultiStage stage.

What is EQT Life Sciences's AUM?

EQT Life Sciences's assets under management are estimated between $1.0B and $10.0B.

Firmographic Details

HeadquartersAmsterdam
Year Founded1988

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?